Modelling the dopamine and noradrenergic cell loss that occurs in Parkinson's disease and the impact on hippocampal neurogenesis.
about
Intracerebroventricularly-administered 1-methyl-4-phenylpyridinium ion and brain-derived neurotrophic factor affect catecholaminergic nerve terminals and neurogenesis in the hippocampus, striatum and substantia nigra.Physiological and Functional Basis of Dopamine Receptors and Their Role in Neurogenesis: Possible Implication for Parkinson's disease.
P2860
Modelling the dopamine and noradrenergic cell loss that occurs in Parkinson's disease and the impact on hippocampal neurogenesis.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Modelling the dopamine and nor ...... t on hippocampal neurogenesis.
@en
Modelling the dopamine and nor ...... t on hippocampal neurogenesis.
@nl
type
label
Modelling the dopamine and nor ...... t on hippocampal neurogenesis.
@en
Modelling the dopamine and nor ...... t on hippocampal neurogenesis.
@nl
prefLabel
Modelling the dopamine and nor ...... t on hippocampal neurogenesis.
@en
Modelling the dopamine and nor ...... t on hippocampal neurogenesis.
@nl
P2860
P50
P356
P1433
P1476
Modelling the dopamine and nor ...... t on hippocampal neurogenesis.
@en
P2093
Jessica A Kauhausen
Stefano Frausin
P2860
P304
P356
10.1002/HIPO.22835
P577
2018-02-24T00:00:00Z